Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.

Hoffmeister PA, Storer BE, Baker KS, Hingorani SR.

Pediatr Blood Cancer. 2014 Mar;61(3):417-23. doi: 10.1002/pbc.24760. Epub 2013 Sep 9.

PMID:
24038785
2.

Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

Hoffmeister PA, Hingorani SR, Storer BE, Baker KS, Sanders JE.

Biol Blood Marrow Transplant. 2010 Apr;16(4):515-24. doi: 10.1016/j.bbmt.2009.11.018. Epub 2009 Dec 2.

3.

Gallstones in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up.

Hoffmeister PA, Storer BE, McDonald GB, Baker KS.

J Pediatr Hematol Oncol. 2014 Aug;36(6):484-90. doi: 10.1097/MPH.0000000000000213.

4.

Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.

Diaz MA, Vicent MG, Gonzalez ME, Verdeguer A, de la Rubia J, Bargay J, de Arriba F, Diez JL, Caballero D, Madero L, Brunet S; Spanish Group for Allogeneic Peripheral Blood Transplantation.

Bone Marrow Transplant. 2004 Sep;34(5):433-8.

PMID:
15273704
5.

Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.

Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1100-7. doi: 10.1016/j.bbmt.2009.05.010.

6.

Chronic kidney disease in long-term survivors of hematopoietic cell transplant.

Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB.

Bone Marrow Transplant. 2007 Feb;39(4):223-9.

PMID:
17290279
7.

Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.

Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.

Biol Blood Marrow Transplant. 2007 Jul;13(7):790-805. Epub 2007 Apr 23.

8.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

9.

Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.

Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS.

Biol Blood Marrow Transplant. 2008 Jun;14(6):658-63. doi: 10.1016/j.bbmt.2008.03.008.

10.

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.

Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1251-7. doi: 10.1016/j.bbmt.2009.05.016.

11.

Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.

Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Tefferi A, Harmsen WS, Litzow MR.

Bone Marrow Transplant. 2001 Jun;27(11):1133-40.

12.

Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.

Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1304-12. Epub 2007 Sep 7.

14.

Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.

Kato K, Yoshimi A, Ito E, Oki K, Hara J, Nagatoshi Y, Kikuchi A, Kobayashi R, Nagamura-Inoue T, Kai S, Azuma H, Takanashi M, Isoyama K, Kato S; Japan Cord Blood Bank Network.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1814-21. doi: 10.1016/j.bbmt.2011.05.013. Epub 2011 May 25.

15.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NK, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ.

Blood. 2007 Nov 15;110(10):3784-92. Epub 2007 Aug 1.

16.

Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.

Friedman DN, Hilden P, Moskowitz CS, Suzuki M, Boulad F, Kernan NA, Wolden SL, Oeffinger KC, Sklar CA.

Biol Blood Marrow Transplant. 2017 Mar;23(3):475-482. doi: 10.1016/j.bbmt.2016.12.623. Epub 2016 Dec 28.

PMID:
28040534
17.

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G.

J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.

18.

Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.

Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.

Bone Marrow Transplant. 2007 Jun;39(11):667-75. Epub 2007 Apr 2.

PMID:
17401396
19.

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.

Künkele A, Engelhard M, Hauffa BP, Mellies U, Müntjes C, Hüer C, Eggert A, Schulte JH, Kremens B.

Pediatr Blood Cancer. 2013 Nov;60(11):1792-7. doi: 10.1002/pbc.24702. Epub 2013 Jul 24.

PMID:
23893964
20.

Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.

Campbell S, Sun CL, Kurian S, Francisco L, Carter A, Kulkarni S, Parker P, Karanes C, Forman SJ, Bhatia S.

Cancer. 2009 Sep 15;115(18):4127-35. doi: 10.1002/cncr.24474.

Supplemental Content

Support Center